Dr. Thomas E. Olencki, DO
- Medicare services, 2018
- 293
- Part D claims, 2018
- 73
- Publications
- 50
- Clinical trials
- 4
- Industry payments
- $8,368
- Practice address
- 8900 N Kendall Dr, Miami, FL 33176
- Practice phone
- Call (614) 293-8619
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Olencki's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Thomas E. Olencki is a medical oncologist in Miami, Florida
Dr. Olencki practices in Miami, Florida.
Dr. Olencki's NPI, 1710994280, was assigned on August 1, 2006. Dr. Olencki holds Ohio license 34005672.
- NPI
- 1710994280NPI Registry (opens in a new tab)
- NPI enumeration date
- August 1, 2006
- NPI status
- Active
- Practice phone
- (614) 293-8619
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Dr. Thomas E. Olencki's practice address is in Miami, Florida
Dr. Olencki's practice address in the NPI Registry is 8900 N Kendall Dr, Miami, FL 33176, in Miami-Dade County. The practice phone is (614) 293-8619.
- NPI Registry address8900 N Kendall Dr, Miami, FL 33176 · Miami-Dade CountyPhone(614) 293-8619
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Thomas E. Olencki's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Olencki practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dr. Olencki's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Thomas E. Olencki is one of 477 medical oncologists in Florida
Medical oncology is Dr. Olencki's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Olencki is licensed in Ohio.
Specialties and state licenses
- Medical oncology, OhioPrimary
Medical oncologists near Dr. Olencki
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Thomas E. Olencki billed Medicare for 293 services in 2018
CMS data shows 293 Medicare services from Dr. Olencki across 2 procedure codes in 2018, all of them office visits. Medicare paid $19,635 for them.
Dr. Olencki's Medicare services by type, 2017 to 2018
- 2017
- 2018
- Office and hospital visits
- 2017: 7272018: 29360%
Where Dr. Olencki's Medicare services took place, 2018
- In an office13747%
- In a facility15653%
Dr. Olencki compared with the Florida median for medical oncologists, 2018
- Dr. Olencki
- Florida median
- Medicare services
- 293vs 19,75599% below
- Part D claims
- 73vs 59888% below
Medians across 462 medical oncologists in Florida with Dmand AI profiles that report each measure.
Dr. Olencki's most billed Medicare procedure codes, 2018
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Olencki?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Olencki and other medical oncologists in Florida.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Thomas E. Olencki's patients have a median age of 73
Across all payers, Dmand AI patient panel data puts Dr. Olencki's median patient age at 73, with 60% women.
Dr. Olencki's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 73
Patient panel by sex, all payers
- Women60%
- Men40%
Source: Dmand AI Patient Panel Data
Dr. Thomas E. Olencki wrote 73 Medicare Part D claims in 2018
In 2018, Dr. Olencki wrote 73 Medicare Part D claims. They cover 5 drugs, with $600,886 in total drug cost. In 2017, CMS named 219 claims across 10 drugs.
Dr. Olencki's most prescribed drugs by claims, 2018
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2017 to 2018
- 2017
- 2018
- Claims for drugs CMS names
- 2017: 2192018: 7367%
Drugs named by CMS: 5 in 2018, 10 in 2017.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Thomas E. Olencki has 50 publications on record
Dmand AI links 50 papers to Dr. Olencki, published from 2011 to 2022. 2018 was the busiest year, with 9. The most frequent topics are Skin Neoplasms, Carcinoma, Renal Cell and Kidney Neoplasms. Dr. Olencki has published most often in J Natl Compr Canc Netw. Dr. Olencki's most frequent co-authors are William E. Carson, MD, Toni K. Choueiri, MD and Kari L. Kendra, MD.
Dr. Olencki's papers by year, 2012 to 2022
Topics Dr. Olencki writes about most
- Skin Neoplasms
- Carcinoma, Renal Cell
- Kidney Neoplasms
- Melanoma
- Antineoplastic Agents
- Carcinoma, Merkel Cell
- Anilides
- Neoplasm Metastasis
Dr. Olencki's most frequent co-authors
- William E. Carson, MD12 shared papers
- Toni K. Choueiri, MD9 shared papers
- Kari L. Kendra, MD9 shared papers
Recent publications by Dr. Olencki
See who Dr. Olencki researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Olencki works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Thomas E. Olencki has worked on 4 clinical trials
Dmand AI links Dr. Olencki to 4 clinical trials, 4 of them phase 2 studies. Conditions studied include Uveal Melanoma, Uveal Neoplasms and Carcinoma, Merkel Cell. National Cancer Institute (NCI) sponsors the most, 2.
Conditions in Dr. Olencki's trials
- Uveal Melanoma
- Uveal Neoplasms
- Carcinoma, Merkel Cell
- Carcinoma, Renal Cell
- Kidney Neoplasms
Investigators on the most trials with Dr. Olencki
- Justine V. Cohen, DO1 shared trial
- Philip A. Friedlander, MD1 shared trial
- Brent Allen Hanks, MD, PhD1 shared trial
Recent clinical trials with Dr. Olencki
Phase II Trial of Adjuvant Crizotinib in High-Risk Uveal Melanoma Following Definitive Therapy (opens in a new tab)
A Phase II Study of MK-3475 in Patients With Advanced Merkel Cell Carcinoma (MCC) (opens in a new tab)
A Phase 2 Study of CDX-011 (Glembatumumab Vedotin) for Metastatic Uveal Melanoma (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Thomas E. Olencki received $8,368 in industry payments from 2016 to 2018
CMS Open Payments shows 14 general payments to Dr. Olencki from 4 drug and device companies from 2016 to 2018. Speaker and faculty fees make up the largest share, 84% of the total. Pfizer Inc. paid the most, $6,732.
General payments to Dr. Olencki by program year, 2016 to 2018
General payments to Dr. Olencki by kind, 2016 to 2018
- Speaker and faculty fees$6,99384%
- Consulting fees$1,07013%
- Food and beverage$2233%
- Education$821%
Companies that paid Dr. Olencki the most, 2016 to 2018
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Thomas E. Olencki's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Thomas E. Olencki
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Thomas E. Olencki's NPI number?
Dr. Thomas E. Olencki's NPI number is 1710994280. It was assigned on August 1, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Thomas E. Olencki?
Dr. Thomas E. Olencki is a medical oncologist in Miami, Florida. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Thomas E. Olencki practice?
Dr. Olencki practices at 8900 N Kendall Dr, Miami, FL 33176.
What is Dr. Thomas E. Olencki's office phone number?
The practice phone on file for Dr. Olencki is (614) 293-8619.
What is Dr. Thomas E. Olencki's medical license number?
Dr. Olencki holds Ohio license 34005672.
Does Dr. Thomas E. Olencki accept Medicare?
Yes. CMS data shows Dr. Olencki billed Medicare for 293 services in 2018.
What services does Dr. Thomas E. Olencki bill to Medicare?
In 2018, Dr. Olencki's most billed Medicare services were office visit, established patient (99215) and office visit, established patient (99214).
What drugs does Dr. Thomas E. Olencki prescribe most?
In 2018 Medicare Part D data, Dr. Olencki's most prescribed drugs by claims were Inlyta, Votrient and Prednisone.
Has Dr. Thomas E. Olencki received payments from drug or device companies?
CMS Open Payments shows $8,368 in general payments to Dr. Olencki from 4 companies from 2016 to 2018. The largest total came from Pfizer Inc.
How long has Dr. Thomas E. Olencki been practicing?
Dr. Olencki's NPI was assigned in 2006.
Does Dr. Thomas E. Olencki do research?
Dmand AI links 50 publications to Dr. Olencki, published from 2011 to 2022. Dr. Olencki has worked on 4 clinical trials.
Who does Dr. Thomas E. Olencki publish with?
Dr. Olencki's most frequent co-authors are William E. Carson, MD (12 shared papers), Toni K. Choueiri, MD (9 shared papers) and Kari L. Kendra, MD (9 shared papers).
Selling to medical oncology practices?
See medical oncologists in Florida by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card